Insider Shareholders with Direct Ownership of Uro Gen Pharma Ltd. (URGN)
This section provides a comprehensive overview of the insiders with direct ownership of Uro Gen Pharma Ltd. (URGN). You can find detailed information about the size and nature of each insider's ownership stake, as well as the latest updates on their holdings.
UroGen Pharma Ltd. Insider List
| Insider | Adquired | Disposed | Held | # of Trades | Last Transaction |
|---|---|---|---|---|---|
|
Arie Belldegrun
Director |
166,482 | 0 | 408,693 $4.62 Million | 3 |
Sep 14, 2022
Added 28.13%
|
|
Elizabeth A. Barrett
Chief Executive Officer |
227,814 | 58,588 | 326,691 $3.69 Million | 10 |
Jan 31, 2023
Added 3.92%
|
|
Mark Schoenberg
Chief Medical Officer |
154,586 | 29,147 | 145,091 $1.64 Million | 40 |
Sep 09, 2024
Reduced 0.59%
|
|
Dong Kim
Chief Financial Officer |
5,833 | 0 | 37,753 $426,608 | 2 |
Sep 09, 2024
Added 6.21%
|
|
Jason Drew Smith
General Counsel |
44,999 | 19,773 | 25,226 $285,053 | 15 |
Sep 09, 2024
Reduced 5.69%
|
|
Peter P. Pfreundschuh
Chief Financial Officer |
4,917 | 2,400 | 10,405 $117,576 | 2 |
Oct 15, 2020
Reduced 8.9%
|
|
Molly Henderson
Chief Financial Officer |
8,166 | 2,918 | 5,248 $59,302 | 5 |
Jan 31, 2022
Reduced 5.93%
|